{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T17:05:16Z","timestamp":1787504716162,"version":"build-2736575974"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T00:00:00Z","timestamp":1747699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T00:00:00Z","timestamp":1747699200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-025-14348-w","type":"journal-article","created":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T13:09:32Z","timestamp":1747746572000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Neurotoxicity associated with cancer chemotherapy: the first study in the Palestinian healthcare system"],"prefix":"10.1186","volume":"25","author":[{"given":"Roqaya","family":"Warrad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aya","family":"Abushar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah","family":"Qubbaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sultan","family":"Mosleh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Razan","family":"Odeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Abuhassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramzi","family":"Shawahna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,20]]},"reference":[{"issue":"1","key":"14348_CR1","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.21763","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73(1):17\u201348.","journal-title":"CA Cancer J Clin"},{"issue":"7","key":"14348_CR2","doi-asserted-by":"publisher","first-page":"e359","DOI":"10.1016\/S1470-2045(18)30323-1","volume":"19","author":"K Halahleh","year":"2018","unstructured":"Halahleh K, Gale RP. Cancer care in the Palestinian territories. Lancet Oncol. 2018;19(7):e359\u201364.","journal-title":"Lancet Oncol"},{"key":"14348_CR3","doi-asserted-by":"crossref","unstructured":"Ferlay J, Colombet M, Soerjomataram I, Parkin DM, Pi\u00f1eros M, Znaor A, Bray F. Cancer statistics for the year 2020: an overview. Int J Cancer. 2021;149:778\u2013789.","DOI":"10.1002\/ijc.33588"},{"key":"14348_CR4","volume-title":"Gaza strip and West bank, source: Globocan 2022","author":"WH Organization","year":"2022","unstructured":"Organization WH. Gaza strip and West bank, source: Globocan 2022. In. Geneva, Switzerland: International Agency for Research on Cancer; 2022."},{"key":"14348_CR5","doi-asserted-by":"crossref","unstructured":"Charmsaz S, Collins DM, Perry AS, Prencipe M. Novel Strategies for Cancer Treatment: Highlights from the 55th IACR Annual Conference. Cancers (Basel) 2019;11(8).","DOI":"10.3390\/cancers11081125"},{"issue":"6","key":"14348_CR6","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/s41568-022-00450-9","volume":"22","author":"L Wang","year":"2022","unstructured":"Wang L, Lankhorst L, Bernards R. Exploiting senescence for the treatment of cancer. Nat Rev Cancer. 2022;22(6):340\u201355.","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"14348_CR7","doi-asserted-by":"publisher","first-page":"315","DOI":"10.3322\/caac.21665","volume":"71","author":"E Butler","year":"2021","unstructured":"Butler E, Ludwig K, Pacenta HL, Klesse LJ, Watt TC, Laetsch TW. Recent progress in the treatment of cancer in children. CA Cancer J Clin. 2021;71(4):315\u201332.","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"14348_CR8","first-page":"1646","volume":"26","author":"J Dietrich","year":"2020","unstructured":"Dietrich J. Neurotoxicity of Cancer therapies. Continuum (Minneap Minn). 2020;26(6):1646\u201372.","journal-title":"Continuum (Minneap Minn)"},{"issue":"2","key":"14348_CR9","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/nrclinonc.2015.152","volume":"13","author":"JB Stone","year":"2016","unstructured":"Stone JB, DeAngelis LM. Cancer-treatment-induced neurotoxicity\u2013focus on newer treatments. Nat Reviews Clin Oncol. 2016;13(2):92\u2013105.","journal-title":"Nat Reviews Clin Oncol"},{"issue":"4","key":"14348_CR10","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1055\/s-2004-861536","volume":"24","author":"EJ Dropcho","year":"2004","unstructured":"Dropcho EJ. Neurotoxicity of cancer chemotherapy. Semin Neurol. 2004;24(4):419\u201326.","journal-title":"Semin Neurol"},{"issue":"6","key":"14348_CR11","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1002\/ana.24951","volume":"81","author":"NP Staff","year":"2017","unstructured":"Staff NP, Grisold A, Grisold W, Windebank AJ. Chemotherapy-induced peripheral neuropathy: A current review. Ann Neurol. 2017;81(6):772\u201381.","journal-title":"Ann Neurol"},{"issue":"1\u20132","key":"14348_CR12","first-page":"36","volume":"15","author":"JC Pendergrass","year":"2018","unstructured":"Pendergrass JC, Targum SD, Harrison JE. Cognitive impairment associated with cancer: A brief review. Innovations Clin Neurosci. 2018;15(1\u20132):36\u201344.","journal-title":"Innovations Clin Neurosci"},{"issue":"1","key":"14348_CR13","doi-asserted-by":"publisher","first-page":"102","DOI":"10.3109\/09540261.2013.864260","volume":"26","author":"MC Janelsins","year":"2014","unstructured":"Janelsins MC, Kesler SR, Ahles TA, Morrow GR. Prevalence, mechanisms, and management of cancer-related cognitive impairment. Int Rev Psychiatry. 2014;26(1):102\u201313.","journal-title":"Int Rev Psychiatry"},{"issue":"4","key":"14348_CR14","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1007\/s11764-020-00944-1","volume":"15","author":"J Lauritsen","year":"2021","unstructured":"Lauritsen J, Bandak M, Kreiberg M, Skott JW, Wagner T, Rosenvilde JJ, Dysager L, Agerbaek M, Daugaard G. Long-term neurotoxicity and quality of life in testicular cancer survivors-a nationwide cohort study. J cancer Survivorship: Res Pract. 2021;15(4):509\u201317.","journal-title":"J cancer Survivorship: Res Pract"},{"issue":"1","key":"14348_CR15","doi-asserted-by":"publisher","first-page":"68","DOI":"10.4103\/apjon.apjon_51_20","volume":"8","author":"YN Chan","year":"2021","unstructured":"Chan YN, Jheng YW, Wang YJ. Chemotherapy-Induced peripheral neurotoxicity as A risk factor for poor sleep quality in breast Cancer survivors treated with docetaxel. Asia-Pacific J Oncol Nurs. 2021;8(1):68\u201373.","journal-title":"Asia-Pacific J Oncol Nurs"},{"issue":"12","key":"14348_CR16","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1016\/j.pain.2014.09.020","volume":"155","author":"M Seretny","year":"2014","unstructured":"Seretny M, Currie GL, Sena ES, Ramnarine S, Grant R, MacLeod MR, Colvin LA, Fallon M. Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: A systematic review and meta-analysis. Pain. 2014;155(12):2461\u201370.","journal-title":"Pain"},{"issue":"1","key":"14348_CR17","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s40425-019-0617-x","volume":"7","author":"DB Johnson","year":"2019","unstructured":"Johnson DB, Manouchehri A, Haugh AM, Quach HT, Balko JM, Lebrun-Vignes B, Mammen A, Moslehi JJ, Salem JE. Neurologic toxicity associated with immune checkpoint inhibitors: a pharmacovigilance study. J Immunother Cancer. 2019;7(1):134.","journal-title":"J Immunother Cancer"},{"issue":"12","key":"14348_CR18","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1001\/jamaoncol.2018.3923","volume":"4","author":"DY Wang","year":"2018","unstructured":"Wang DY, Salem JE, Cohen JV, Chandra S, Menzer C, Ye F, Zhao S, Das S, Beckermann KE, Ha L, et al. Fatal toxic effects associated with immune checkpoint inhibitors: A systematic review and Meta-analysis. JAMA Oncol. 2018;4(12):1721\u20138.","journal-title":"JAMA Oncol"},{"issue":"4","key":"14348_CR19","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1080\/14740338.2020.1738382","volume":"19","author":"AM Haugh","year":"2020","unstructured":"Haugh AM, Probasco JC, Johnson DB. Neurologic complications of immune checkpoint inhibitors. Expert Opin Drug Saf. 2020;19(4):479\u201388.","journal-title":"Expert Opin Drug Saf"},{"issue":"1","key":"14348_CR20","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1186\/s43055-021-00606-x","volume":"52","author":"MAA Abdou","year":"2021","unstructured":"Abdou MAA, El Kiki HA, Madney Y, Youssef AA. Chemotherapy-related neurotoxicity in pediatric cancer patients: magnetic resonance imaging and clinical correlation. Egypt J Radiol Nuclear Med. 2021;52(1):230.","journal-title":"Egypt J Radiol Nuclear Med"},{"issue":"5","key":"14348_CR21","doi-asserted-by":"publisher","first-page":"587","DOI":"10.3109\/0284186X.2014.995775","volume":"54","author":"M Ewertz","year":"2015","unstructured":"Ewertz M, Qvortrup C, Eckhoff L. Chemotherapy-induced peripheral neuropathy in patients treated with taxanes and platinum derivatives. Acta Oncol. 2015;54(5):587\u201391.","journal-title":"Acta Oncol"},{"key":"14348_CR22","doi-asserted-by":"crossref","unstructured":"Vilari\u00f1o N, Bruna J, Kalofonou F, Anastopoulou GG, Argyriou AA. Immune-Driven pathogenesis of neurotoxicity after exposure of Cancer patients to immune checkpoint inhibitors. Int J Mol Sci 2020;21(16).","DOI":"10.3390\/ijms21165774"},{"key":"14348_CR23","doi-asserted-by":"publisher","first-page":"750507","DOI":"10.3389\/fphar.2022.750507","volume":"13","author":"H Was","year":"2022","unstructured":"Was H, Borkowska A, Bagues A, Tu L, Liu JYH, Lu Z, Rudd JA, Nurgali K, Abalo R. Mechanisms of Chemotherapy-Induced neurotoxicity. Front Pharmacol. 2022;13:750507.","journal-title":"Front Pharmacol"},{"issue":"1","key":"14348_CR24","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s12885-019-5302-4","volume":"19","author":"A Molassiotis","year":"2019","unstructured":"Molassiotis A, Cheng HL, Lopez V, Au JSK, Chan A, Bandla A, Leung KT, Li YC, Wong KH, Suen LKP, et al. Are we mis-estimating chemotherapy-induced peripheral neuropathy? Analysis of assessment methodologies from a prospective, multinational, longitudinal cohort study of patients receiving neurotoxic chemotherapy. BMC Cancer. 2019;19(1):132.","journal-title":"BMC Cancer"},{"key":"14348_CR25","doi-asserted-by":"crossref","unstructured":"D\u2019Souza RS, Saini C, Hussain N, Javed S, Prokop L, Her YF. Global estimates of prevalence of chronic painful neuropathy among patients with chemotherapy-induced peripheral neuropathy: systematic review and meta-analysis of data from 28 countries, 2000-24.Regional anesthesia and pain medicine 2025.","DOI":"10.1136\/rapm-2024-106229"},{"issue":"1","key":"14348_CR26","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1002\/cam4.571","volume":"5","author":"T Iwase","year":"2016","unstructured":"Iwase T, Sangai T, Nagashima T, Sakakibara M, Sakakibara J, Hayama S, Ishigami E, Masuda T, Miyazaki M. Impact of body fat distribution on neoadjuvant chemotherapy outcomes in advanced breast cancer patients. Cancer Med. 2016;5(1):41\u20138.","journal-title":"Cancer Med"},{"issue":"10","key":"14348_CR27","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.urolonc.2022.07.013","volume":"40","author":"A Phuong","year":"2022","unstructured":"Phuong A, Marquardt JP, O\u2019Malley R, Holt SK, Laidlaw G, Eagle Z, Ngo S, Orcutt D, Schade GR, Lin DW, et al. Changes in skeletal muscle and adipose tissue during cytotoxic chemotherapy for testicular germ cell carcinoma and associations with adverse events. Urol Oncol. 2022;40(10):456. e419-456 e430.","journal-title":"Urol Oncol"},{"issue":"3","key":"14348_CR28","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1007\/s10549-020-05731-1","volume":"182","author":"GFP Aleixo","year":"2020","unstructured":"Aleixo GFP, Shachar SS, Deal AM, Nyrop KA, Muss HB, Chen YT, Yu H, Williams GR. The association of body composition parameters and adverse events in women receiving chemotherapy for early breast cancer. Breast Cancer Res Treat. 2020;182(3):631\u201342.","journal-title":"Breast Cancer Res Treat"},{"issue":"6","key":"14348_CR29","doi-asserted-by":"publisher","first-page":"419","DOI":"10.3322\/caac.21204","volume":"63","author":"SB Park","year":"2013","unstructured":"Park SB, Goldstein D, Krishnan AV, Lin CS, Friedlander ML, Cassidy J, Koltzenburg M, Kiernan MC. Chemotherapy-induced peripheral neurotoxicity: a critical analysis. CA Cancer J Clin. 2013;63(6):419\u201337.","journal-title":"CA Cancer J Clin"},{"key":"14348_CR30","doi-asserted-by":"crossref","unstructured":"Zajaczkowska R, Kocot-Kepska M, Leppert W, Wrzosek A, Mika J, Wordliczek J. Mechanisms of Chemotherapy-Induced peripheral neuropathy. Int J Mol Sci 2019;20(6).","DOI":"10.3390\/ijms20061451"},{"issue":"1","key":"14348_CR31","doi-asserted-by":"publisher","first-page":"59","DOI":"10.2174\/157016307781115485","volume":"4","author":"J Wang","year":"2007","unstructured":"Wang J, Huang Y. Pharmacogenomics of sex difference in chemotherapeutic toxicity. Curr Drug Discov Technol. 2007;4(1):59\u201368.","journal-title":"Curr Drug Discov Technol"},{"key":"14348_CR32","doi-asserted-by":"crossref","unstructured":"Ozdemir BC, Gerard CL, Espinosa da Silva C. Sex and gender differences in anticancer treatment toxicity: A call for revisiting drug dosing in oncology. Endocrinology 2022;163(6).","DOI":"10.1210\/endocr\/bqac058"},{"key":"14348_CR33","doi-asserted-by":"crossref","unstructured":"Seydoux C, Briki M, Wagner AD, Choong E, Guidi M, Carrara S, Thoma Y, Livio F, Girardin FR, Marzolini C et al. Importance of Sex-Dependent differences for dosing selection and optimization of chemotherapeutic drugs. Chemotherapy 2024. 1\u201310.","DOI":"10.1159\/000542461"},{"issue":"12","key":"14348_CR34","doi-asserted-by":"publisher","first-page":"7461","DOI":"10.1007\/s00520-021-06321-7","volume":"29","author":"J Gu","year":"2021","unstructured":"Gu J, Lu H, Chen C, Gu Z, Hu M, Liu L, Yu J, Wei G, Huo J. Diabetes mellitus as a risk factor for chemotherapy-induced peripheral neuropathy: a meta-analysis. Supportive Care Cancer: Official J Multinational Association Supportive Care Cancer. 2021;29(12):7461\u20139.","journal-title":"Supportive Care Cancer: Official J Multinational Association Supportive Care Cancer"},{"issue":"4","key":"14348_CR35","doi-asserted-by":"publisher","first-page":"3124","DOI":"10.3390\/curroncol28040273","volume":"28","author":"M Sempere-Bigorra","year":"2021","unstructured":"Sempere-Bigorra M, Julian-Rochina I, Cauli O. Chemotherapy-Induced neuropathy and diabetes: A scoping review. Curr Oncol. 2021;28(4):3124\u201338.","journal-title":"Curr Oncol"},{"issue":"4","key":"14348_CR36","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1007\/s00520-019-05023-5","volume":"28","author":"AA Argyriou","year":"2020","unstructured":"Argyriou AA, Bruna J, Anastopoulou GG, Velasco R, Litsardopoulos P, Kalofonos HP. Assessing risk factors of falls in cancer patients with chemotherapy-induced peripheral neurotoxicity. Supportive Care Cancer: Official J Multinational Association Supportive Care Cancer. 2020;28(4):1991\u20135.","journal-title":"Supportive Care Cancer: Official J Multinational Association Supportive Care Cancer"},{"issue":"1","key":"14348_CR37","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s12984-021-00818-2","volume":"18","author":"AB Wang","year":"2021","unstructured":"Wang AB, Housley SN, Flores AM, Kircher SM, Perreault EJ, Cope TC. A review of movement disorders in chemotherapy-induced neurotoxicity. J Neuroeng Rehabil. 2021;18(1):16.","journal-title":"J Neuroeng Rehabil"},{"issue":"7","key":"14348_CR38","doi-asserted-by":"publisher","first-page":"e660","DOI":"10.1212\/WNL.0000000000012300","volume":"97","author":"P Alberti","year":"2021","unstructured":"Alberti P, Bernasconi DP, Cornblath DR, Merkies ISJ, Park SB, Velasco R, Bruna J, Psimaras D, Koeppen S, Pace A, et al. Prospective evaluation of health care provider and patient assessments in Chemotherapy-Induced peripheral neurotoxicity. Neurology. 2021;97(7):e660\u201372.","journal-title":"Neurology"},{"issue":"7","key":"14348_CR39","doi-asserted-by":"publisher","first-page":"821","DOI":"10.6004\/jnccn.2021.7026","volume":"19","author":"E Battaglini","year":"2021","unstructured":"Battaglini E, Goldstein D, Grimison P, McCullough S, Mendoza-Jones P, Park SB. Chemotherapy-Induced peripheral neurotoxicity in Cancer survivors: predictors of Long-Term patient outcomes. J Natl Compr Canc Netw. 2021;19(7):821\u20138.","journal-title":"J Natl Compr Canc Netw"},{"issue":"9","key":"14348_CR40","doi-asserted-by":"publisher","first-page":"3269","DOI":"10.1007\/s00415-020-09942-w","volume":"268","author":"L Kang","year":"2021","unstructured":"Kang L, Tian Y, Xu S, Chen H. Oxaliplatin-induced peripheral neuropathy: clinical features, mechanisms, prevention and treatment. J Neurol. 2021;268(9):3269\u201382.","journal-title":"J Neurol"},{"key":"14348_CR41","doi-asserted-by":"crossref","unstructured":"Kawashiri T, Mine K, Kobayashi D, Inoue M, Ushio S, Uchida M, Egashira N, Shimazoe T. Therapeutic agents for Oxaliplatin-Induced peripheral neuropathy; experimental and clinical evidence. Int J Mol Sci 2021;22(3).","DOI":"10.3390\/ijms22031393"},{"issue":"2","key":"14348_CR42","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1080\/17425255.2021.1856367","volume":"17","author":"DL Hertz","year":"2021","unstructured":"Hertz DL. Exploring pharmacogenetics of paclitaxel- and docetaxel-induced peripheral neuropathy by evaluating the direct pharmacogenetic-pharmacokinetic and pharmacokinetic-neuropathy relationships. Expert Opin Drug Metab Toxicol. 2021;17(2):227\u201339.","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"6","key":"14348_CR43","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1007\/s12640-022-00582-8","volume":"40","author":"R Velasco-Gonzalez","year":"2022","unstructured":"Velasco-Gonzalez R, Coffeen U. Neurophysiopathological aspects of Paclitaxel-induced peripheral neuropathy. Neurotox Res. 2022;40(6):1673\u201389.","journal-title":"Neurotox Res"},{"key":"14348_CR44","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.clinph.2023.08.002","volume":"154","author":"T Li","year":"2023","unstructured":"Li T, Kandula T, Cohn RJ, Kiernan MC, Park SB, Farrar MA. Prospective assessment of vincristine-induced peripheral neuropathy in paediatric acute lymphoblastic leukemia. Clin Neurophysiology: Official J Int Federation Clin Neurophysiol. 2023;154:157\u201368.","journal-title":"Clin Neurophysiology: Official J Int Federation Clin Neurophysiol"},{"key":"14348_CR45","doi-asserted-by":"crossref","unstructured":"Yamamoto S, Egashira N. Pathological mechanisms of Bortezomib-Induced peripheral neuropathy. Int J Mol Sci 2021;22(2).","DOI":"10.3390\/ijms22020888"},{"key":"14348_CR46","doi-asserted-by":"publisher","first-page":"112068","DOI":"10.1016\/j.biopha.2021.112068","volume":"142","author":"W Yan","year":"2021","unstructured":"Yan W, Wu Z, Zhang Y, Hong D, Dong X, Liu L, Rao Y, Huang L, Zhang X, Wu J. The molecular and cellular insight into the toxicology of bortezomib-induced peripheral neuropathy. Biomed pharmacotherapy = Biomedecine Pharmacotherapie. 2021;142:112068.","journal-title":"Biomed pharmacotherapy = Biomedecine Pharmacotherapie"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-14348-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-025-14348-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-14348-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T13:09:36Z","timestamp":1747746576000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-025-14348-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,20]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["14348"],"URL":"https:\/\/doi.org\/10.1186\/s12885-025-14348-w","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,20]]},"assertion":[{"value":"15 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in compliance with international ethical principles in scientific research, including those stated in the Declaration of Helsinki. It was approved by the Institutional Review Board of An-Najah National University (Ref. no. Med. Oct. 2023\/69). Permissions were obtained from the administrations of the participating hospitals and centers, enabling access to patients. Written informed consent was obtained from all patients prior to their participation. The confidentiality of data and the privacy of patients were strictly maintained.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"All authors report no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"904"}}